Davide Rizzo
Papers
1
Total Citations
8
H-Index
1
About
Davide Rizzo is a leading surgical oncologist whose work centers on the treatment of head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinomas (OPSCCs) and the role of human papillomavirus (HPV). His most cited research critically examines the evidence for transoral robotic surgery (TORS) in HPV-driven oropharyngeal cancer, a rapidly evolving area where treatment de-intensification is a key goal. In his highly influential 2023 systematic review, Rizzo challenges the prevailing enthusiasm for TORS by questioning whether sufficient evidence exists to specifically recommend it over other modalities for p16-positive patients. This work, which has already garnered 8 citations, underscores his commitment to evidence-based surgical practice and patient-centered outcomes. By rigorously evaluating the intersection of robotic technology, viral etiology, and oncologic safety, Rizzo has established himself as a thoughtful voice in the debate on how to balance de-escalation with efficacy. His scholarship is essential reading for clinicians and researchers navigating the complexities of modern head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1